CRP and COVID-19: This finding of higher CRP for improved survival in TCZ recipients is contradictory to the finding in the overall population with COVID-19 [31].The lower CRP in deceased patients could be as these patients might have developed a late flare of illness after administration of TCZ, and additionally, these are the patients who also have chronic conditions such as CKD and diabetes which makes them immunologically compromised.